Submitted:
19 August 2024
Posted:
20 August 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Drainage of Subcutaneous after Cytoreduction for Ovarian Cancer
4. Drainage Following Vaginal or Laparoscopic Hysterectomy
5. Drainage Following Radical Hysterectomy and Lymphadenectomy or Lymphadenectomy for Various Gynecological Malignancies (Pelvic and/or Para-Aortic)
6. Drainage Following Complex Debulking with Colectomy and Peritonectomy
7. Guidelines
8. Conclusions and Future Directions
Author Contributions
Funding
Institutional Review Board Statement
Conflicts of Interest
References
- References must be numbered in order of appearance in the text (including citations in tables and legends) and listed Moss JP. 1981. Historical and current perspectives on surgical drainage.Surgery, Gynecology & Obstetrics 152:517–527.
- Zhang HY, Zhao CL, Xie J, Ye YW, Sun JF, Ding ZH, Xu HN, et al. 2016. To drain or not to drain in colorectal anastomosis: a meta-analysis.International Journal of Colorectal Disease 31:951–96. [CrossRef]
- Rebibo L, Ebosse I, Iederan C, Mahjoub Y, Dupont H, Cosse C, RegimbeauJM. 2017. Does drainage of the peritoneal cavity have an impact onthe postoperative course of community-acquired, secondary, lowergastrointestinal tract peritonitis? American Journal of Surgery 214:29–36.
- Asgari Z, Hosseini R, Rastad H, Hosseini L. 2018. Does peritoneal suctiondrainage reduce pain after gynecologic laparoscopy? SurgicalLaparoscopy, Endoscopy & Percutaneous Techniques 28:73–76.
- World Health Organization 2021, World Health Organization website, accessed 1 February 2023, Caesarean section rates continue to rise, amid growing inequalities in access (who.int).
- Charoenkwan, K.; Kietpeerakool, C. Retroperitoneal Drainage versus No Drainage after Pelvic Lymphadenectomy for the Prevention of Lymphocyst Formation in Women with Gynaecological Malignancies. Cochrane Database Syst Rev 2017, 6 (6), CD007387. [CrossRef]
- Betran AP, Ye J, Moller AB et al. The increasing trend in caesareansection rates: global, regional and National Estimates: 1990-2014.PLoS One 2016; 11(2): e0148343.
- Gallup DC, Gallup DG, Nolan TE, et al. Use of a subcutaneous closed drainage system and antibiotics in obese gynecologic patients. Am J Obstet Gynecol. 1996;175:358Y361.
- Cardosi RJ, Drake J, Holmes S, et al. Subcutaneous management of vertical incisions with 3 or more centimeters of subcutaneous fat. Am J Obstet Gynecol. 2006;195: 607Y614. [CrossRef]
- Panici PB, Zullo MA, Casalino B, et al. Subcutaneous drainage versus no drainage after minilaparotomy in gynecologic benign conditions: a randomized study. Am J Obstet Gynecol. 2003;188:71Y75. [CrossRef]
- Kim, Se Ik et al. “Benefit of negative pressure drain within surgical wound after cytoreductive surgery for ovarian cancer.” International journal of gynecological cancer: official journal of the International Gynecological Cancer Society vol. 25,1 (2015): 145-51. [CrossRef]
- Chung, Young Shin et al. “Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancer.” International journal of gynecological cancer: official journal of the International Gynecological Cancer Society vol. 31,2 (2021): 245-250. [CrossRef]
- Kim, Se Ik et al. “Application of a subcutaneous negative pressure drain without subcutaneous suture: impact on wound healing in gynecologic surgery.” European journal of obstetrics, gynecology, and reproductive biology vol. 173 (2014): 94-100. [CrossRef]
- ACOG Committee Opinion No. 444: choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2009;114(5):1156–1158.
- AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL position statement: route of hysterectomy to treat benign uterine disease. J Minim Invasive Gynecol. 2011;18(1):1–3.
- Cohen SL, Vitonis AF, Einarsson JI. Updated hysterectomy surveillance and factors associated with minimally invasive hysterectomy. JSLS. 2014 Jul-Sep;18(3):e2014.00096. [CrossRef] [PubMed]
- Akan S, et al. "Incidence of Vault Hematoma after Abdominal Hysterectomy." Obstetrics & Gynecology. 2005; 106(2): 354-359.
- Krishnaswamy, P.H.; Jha, S.; Krishnan, M. Efficiency of Using a Vaginal Drain after Hysterectomy: A Systematic Review. Eur J Obstet Gynecol Reprod Biol 2019, 237, 175–180. [Google Scholar] [CrossRef] [PubMed]
- Shen, Chung-Chang et al. “A prospective, randomized study of closed-suction drainage after laparoscopic-assisted vaginal hysterectomy.” The Journal of the American Association of Gynecologic Laparoscopists vol. 9,3 (2002): 346-52. [CrossRef]
- Oh, S.; Chon, S.J.; Lee, S.H.; Shin, J.W. Vaginal Vault Drainage as an Effective and Feasible Alternative in Laparoscopic Hysterectomy. Obstet Gynecol Sci 2022, 65, 477–482. [Google Scholar] [CrossRef] [PubMed]
- Jensen JK, Lucci JA, Saja PJ, Manetta A, Berman ML. To drain or not to drain: a retrospective study of closed-suction drainage following radical hysterectomy with pelvic lymphadenectomy. Gynecol Oncol 1993;51:46–9. [CrossRef]
- Srisomboon, J.; Phongnarisorn, C.; Suprasert, P.; Cheewakriangkrai, C.; Siriaree, S.; Charoenkwan, K. A Prospective Randomized Study Comparing Retroperitoneal Drainage with No Drainage and No Peritonization Following Radical Hysterectomy and Pelvic Lymphadenectomy for Invasive Cervical Cancer. J Obstet Gynaecol Res 2002, 28, 149–153. [Google Scholar] [CrossRef] [PubMed]
- Franchi, M.; Trimbos, J. B.; Zanaboni, F.; v d Velden, J.; Reed, N.; Coens, C.; Teodorovic, I.; Vergote, I. Randomised Trial of Drains versus No Drains Following Radical Hysterectomy and Pelvic Lymph Node Dissection: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) Study in 234 Patients. Eur J Cancer 2007, 43, 1265–1268. [Google Scholar] [CrossRef] [PubMed]
- Patsner, B. Closed-Suction Drainage versus No Drainage Following Radical Abdominal Hysterectomy with Pelvic Lymphadenectomy for Stage IB Cervical Cancer. Gynecol Oncol 1995, 57, 232–234. [Google Scholar] [CrossRef] [PubMed]
- Bafna, U. D.; Umadevi, K.; Savitha, M. Closed Suction Drainage versus No Drainage Following Pelvic Lymphadenectomy for Gynecological Malignancies. Int J Gynecol Cancer 2001, 11, 143–146. [Google Scholar] [CrossRef] [PubMed]
- Morice, P.; Lassau, N.; Pautier, P.; Haie-Meder, C.; Lhomme, C.; Castaigne, D. Retroperitoneal Drainage after Complete Para-Aortic Lymphadenectomy for Gynecologic Cancer: A Randomized Trial. Obstet Gynecol 2001, 97, 243–247. [Google Scholar] [CrossRef] [PubMed]
- Conte M, Panici PB, Guarglia L, Scambia G, Greggi S, Mancuso S. Pelvic lymphocele following radical paraaortic and pelvic lymphadenectomy for cervical carcinoma: incidence rate and percutaneous management. Obstet Gynecol 1990;76:268–71.
- Chi DS, Eisenhauer EL, Zivanovic O, et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 2009;114:26Y31. [CrossRef]
- Mourton SM, Temple LK, Abu-Rustum NR, et al. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 2005;99:608Y614. [CrossRef]
- Richardson DL, Mariani A, Cliby WA. Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer. Gynecol Oncol. 2006;103:667Y672. [CrossRef]
- Kato, K.; Omatsu, K.; Matoda, M.; Nomura, H.; Okamoto, S.; Kanao, H.; Utsugi, K.; Takeshima, N. Efficacy of Transanal Drainage Tube Placement After Modified Posterior Pelvic Exenteration for Primary Ovarian Cancer. Int J Gynecol Cancer 2018, 28, 220–225. [Google Scholar] [CrossRef] [PubMed]
- Petrowsky H, Demartines N, Rousson V, Clavien PA. Evidencebased value of prophylactic drainage in gastrointestinal surgery: a systematic review and meta-analyses. Ann Surg 2004;240(6):1074–1084.
- Merad F, Yahchouchi E, Hay JM, Fingerhut A, Laborde Y, Langlois-Zantain O. Prophylactic abdominal drainage after elective colonic resection and suprapromontory anastomosis: a multicenter study controlled by randomization. French Associations for Surgical Research. Arch Surg 1998;133(3):309–314. [CrossRef]
- Yamaguchi, S.; Tsutsumi, S.; Fujii, T.; Morita, H.; Suto, T.; Nakajima, M.; Kato, H.; Asao, T.; Kuwano, H. Prophylactic and Informational Abdominal Drainage Is Not Necessary after Colectomy and Suprapromontory Anastomosis. Int Surg 2013, 98, 307–310. [Google Scholar] [CrossRef] [PubMed]
- ACOG Committee Opinion, No. 750: Perioperative Pathways: Enhanced Recovery After Surgery. Obstet Gynecol 2018, 132, e120–e130. [Google Scholar] [CrossRef]
- Fotopoulou, C.; Planchamp, F.; Aytulu, T.; Chiva, L.; Cina, A.; Ergönül, Ö.; Fagotti, A.; Haidopoulos, D.; Hasenburg, A.; Hughes, C.; et al. European Society of Gynaecological Oncology Guidelines for the Peri-Operative Management of Advanced Ovarian Cancer Patients Undergoing Debulking Surgery. Int J Gynecol Cancer 2021, 31, 1199–1206. [Google Scholar] [CrossRef] [PubMed]
| Type of Study | Patients | Type of Operation | Febrile Morbidity Rates (Drain vs No Drain) |
Mean Length of Hospital Stay in Days (Drain vs No Drain) |
Lymphocysts Formation (Drain vs No Drain) |
Postoperative Complications (Drain vs No Drain) |
|
|---|---|---|---|---|---|---|---|
| Jensen et al. [21] | Retrospective cohort | Early-stage cervical cancer | RHPL1 | 32,8% vs 29,1% (NS2) |
7,6 ± 2,4 vs 7,0 ± 1,3 (NS2) |
- | - |
| Srisomboon et al. [22] | Prospective randomized | Early-stage cervical cancer | RHPL1 | 5,8% vs 0% (NS2) | 9.4 ± 1.6 vs 9.2 ± 1.4 (NS2) |
NS2, p=0,2 | - |
| Franchi et al. [23] | Prospective randomized | Early-stage cervical cancer | RHPL1 | - | - | 5.9% vs 0.9% (NS2, p=0,06) |
0,53% vs 0,66% (NS2) |
| Patsner et al. [24] | Prospective non-randomized study |
Early-stage cervical cancer | RHPL1 | 10% vs 3,3% (NS2) | 5,5 vs 4,5 (NS2) |
11,6% vs 0% (NS2) |
|
| Charoenkwan et al. [6] | Systematic review | Various gynecologic malignancies | Systematic pelvic or pelvic and aortic 3LND | - | - | NS2 | - |
| Bafna et al. [25] | Prospective non-randomized | Various gynecologic malignancies | Pelvic ± aortocaval 3LND |
- | 10 vs 10 (NS2) |
7,2% vs 2,7% (NS2, p>0,05) |
- |
| Morice et al. [26] | Randomized trial | Ovarian or cervical carcinoma | Complete para-aortic 3LND up to the level of the left renal vein | - | 11 vs 9 (P<.03) |
5% vs 24% (P<0,05) |
36% vs 13% (P<0,02) |
| Tubes. | Upper Abdominal Complications | Diaphragmatic Surgery | Pleural Effusion | Post-Op Collections or Abscess | Diet | Urinary Catheter |
|---|---|---|---|---|---|---|
| ESGO guidelines [36] | Could be considered in large-volume ascites and extensive peritoneal and/or lymph node resections (III, C) |
Not routinely indicated (III, B) |
Could be considered in cases of high-volume pre-operative pleura effusion, frailty, hypoalbuminemia, and large diaphragmatic resection (III, B) | Preferable management: Image-guided percutaneous drainage (III, B) |
- | - |
| ACOG committee opinion and ERAS protocol [35] |
Avoidance of drains and vaginal packs |
-No nasogastric tube -Regular diet and gum chewing 4 hours post-operatively |
Removal within 24 hours |
|||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).